Kenneth J. Shaw

2.8k total citations
26 papers, 1.4k citations indexed

About

Kenneth J. Shaw is a scholar working on Hematology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Kenneth J. Shaw has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Kenneth J. Shaw's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Signaling Pathways in Disease (4 papers). Kenneth J. Shaw is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Signaling Pathways in Disease (4 papers). Kenneth J. Shaw collaborates with scholars based in United States, Japan and Canada. Kenneth J. Shaw's co-authors include Diane Pennica, Shiuh-Ming Luoh, Todd A. Swanson, Walter C. Darbonne, E. Luis, Deborah S. Knutzon, K. L. King, Kenneth R. Chien, William I. Wood and David L. Shelton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Kenneth J. Shaw

25 papers receiving 1.4k citations

Peers

Kenneth J. Shaw
Vered Klinghofer United States
Peter D. Davis United Kingdom
Peter P. Sayeski United States
Geoffrey Lawton United Kingdom
Lori J. Pease United States
John L. Herrmann United States
John Wityak United States
Robert T. Dorsam United States
Christopher H. Hill United Kingdom
Shin‐ichi Tsukamoto Japan
Vered Klinghofer United States
Kenneth J. Shaw
Citations per year, relative to Kenneth J. Shaw Kenneth J. Shaw (= 1×) peers Vered Klinghofer

Countries citing papers authored by Kenneth J. Shaw

Since Specialization
Citations

This map shows the geographic impact of Kenneth J. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth J. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth J. Shaw more than expected).

Fields of papers citing papers by Kenneth J. Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth J. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth J. Shaw. The network helps show where Kenneth J. Shaw may publish in the future.

Co-authorship network of co-authors of Kenneth J. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth J. Shaw. A scholar is included among the top collaborators of Kenneth J. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth J. Shaw. Kenneth J. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Hua, Kenneth J. Shaw, Jérôme Deval, et al.. (2015). P0682 : Preclinical characterization of AL-335, a potent uridine based nucleoside polymerase inhibitor for the treatment of chronic hepatitis C. Journal of Hepatology. 62. S577–S578. 3 indexed citations
2.
Buckman, Brad O., Amy Liang, Dao Lentz, et al.. (2005). Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(9). 2249–2252. 11 indexed citations
3.
Ye, Bin, Brad O. Buckman, Ameen Ghannam, et al.. (2003). Synthesis and biological evaluation of menthol-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1). Bioorganic & Medicinal Chemistry Letters. 13(19). 3361–3365. 18 indexed citations
4.
Davey, David D., Keith Eagen, Brian D. Griedel, et al.. (2003). Structure–Activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(3). 507–511. 30 indexed citations
5.
Ye, Bin, Wheeseong Lee, Kenneth J. Shaw, et al.. (2003). Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1). Bioorganic & Medicinal Chemistry Letters. 14(3). 761–765. 17 indexed citations
6.
Shaw, Kenneth J., William J. Guilford, Brian D. Griedel, et al.. (2002). Benzimidazole-Based fXa inhibitors with improved thrombin and trypsin selectivity. Bioorganic & Medicinal Chemistry Letters. 12(9). 1311–1314. 6 indexed citations
7.
Wu, Shung, William J. Guilford, Brian D. Griedel, et al.. (2002). Design and synthesis of aminophenol-Based factor xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(9). 1307–1310. 5 indexed citations
8.
Ng, Howard P., Brad O. Buckman, Keith Eagen, et al.. (2002). Design, Synthesis, and Biological Activity of Novel Factor Xa Inhibitors: 4-Aryloxy Substituents of 2,6-Diphenoxypyridines††See ref. 1.. Bioorganic & Medicinal Chemistry. 10(3). 657–666. 6 indexed citations
9.
Zhao, Zuchun, Damian O. Arnaiz, Brian D. Griedel, et al.. (2000). Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(9). 963–966. 97 indexed citations
10.
Arnaiz, Damian O., Zuchun Zhao, Amy Liang, et al.. (2000). Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(9). 957–961. 15 indexed citations
11.
Whitlow, Marc, Brad O. Buckman, David D. Davey, et al.. (1999). Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin. Acta Crystallographica Section D Biological Crystallography. 55(8). 1395–1404. 30 indexed citations
12.
Shaw, Kenneth J., William J. Guilford, Jerry L. Dallas, et al.. (1998). (Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one:  Identification of a Highly Active Inhibitor of Blood Coagulation Factor Xa. Journal of Medicinal Chemistry. 41(19). 3551–3556. 23 indexed citations
13.
Pennica, Diane, et al.. (1996). Human Cardiotrophin-1: Protein and Gene Structure, Biological and Binding Activities, and Chromosomal Localization. Cytokine. 8(3). 183–189. 66 indexed citations
14.
Pennica, Diane, Kenneth J. Shaw, Todd A. Swanson, et al.. (1995). Cardiotrophin-1. Journal of Biological Chemistry. 270(18). 10915–10922. 382 indexed citations
15.
Pennica, Diane, Kenneth J. Shaw, Shiuh-Ming Luoh, & William I. Wood. (1995). Isolation of cDNA clones encoding the mouse protein V-1. Gene. 158(2). 305–306. 8 indexed citations
16.
Pennica, Diane, K. L. King, Kenneth J. Shaw, et al.. (1995). Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.. Proceedings of the National Academy of Sciences. 92(4). 1142–1146. 461 indexed citations
17.
Shaw, Kenneth J., et al.. (1992). Cardiotonic agents. 7. Prodrug derivatives of 4-ethyl-1,3-dihydro-5-[4-(2-methyl-1H-imidazol-1-yl)benzoyl]-2H-imidazol-2-one. Journal of Medicinal Chemistry. 35(7). 1267–1272. 17 indexed citations
18.
Mohan, Raju, et al.. (1991). Synthesis and biological activity of angiotensin II analog containing a Val-His replacement, Val.psi.[CH(CONH2)HN]His. Journal of Medicinal Chemistry. 34(8). 2402–2410. 18 indexed citations
19.
Krapcho, A. Paul, et al.. (1986). Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems. Journal of Medicinal Chemistry. 29(8). 1370–1373. 17 indexed citations
20.
Krapcho, A. Paul & Kenneth J. Shaw. (1983). Synthesis and rearrangements of dihydro-1,4-oxazepine and dihydro-1,4-thiazepine derivatives. The Journal of Organic Chemistry. 48(19). 3341–3343. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vered Klinghofer Breakdown of academic impact, for papers by Peter D. Davis Breakdown of academic impact, for papers by Peter P. Sayeski Breakdown of academic impact, for papers by Geoffrey Lawton Breakdown of academic impact, for papers by Lori J. Pease Breakdown of academic impact, for papers by John L. Herrmann Breakdown of academic impact, for papers by John Wityak Breakdown of academic impact, for papers by Robert T. Dorsam Breakdown of academic impact, for papers by Christopher H. Hill Breakdown of academic impact, for papers by Shin‐ichi Tsukamoto
Rankless by CCL
2026